We tend to describe aging pathways as if they’re clean circuits on a circuit board. But there's a glaring blind spot in longevity science that we rarely admit: we don't really understand intracellular viscosity.

The cytoplasm isn't a well-stirred watery soup. It's a crowded, shifting medium shaped by Liquid-Liquid Phase Separation (LLPS), and as we age, that liquid state starts transitioning into something closer to glass.

When we design small molecules, we assume they'll just diffuse toward a target once they’re inside the membrane. But what if the internal traffic in an old cell is so thick—thanks to macromolecular crowding and failing proteostasis—that the signal can't get through? Your NMN might not even reach its intended enzyme; it might just be stuck in a cytoplasmic gridlock.

We’ve spent decades obsessing over cellular components—the transcriptome and the proteome—while ignoring the medium they actually live in. It’s like studying the cars while the road beneath them turns to wet concrete. This isn't just about localized amyloid plaques; it’s a systemic collapse of the physical state inside our cells.

The thermodynamics of diffusion in an old cell are fundamentally different. If the cytoplasm gets too viscous, rejuvenation factors won’t fix anything. They’ll just sit there, adding to the clutter.

We need to stop looking at the aging cell as just a parts list and start seeing it as a failing material state. That means we need physicists and biophysicists to help us figure out how to reset the cell’s physical phase. If we can't keep the interior liquid, even the best gene editing won't save us. You can't paint a masterpiece on a canvas that’s already hardened into stone.